(Q74445927)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Deregulated cytokine network and defective Th1 immune response in multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

M A Frassanito

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Cusmai

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

F Dammacco

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529908%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

190-197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529908%20AND%20SRC:MED&resulttype=core&format=json

Serum interleukin-6 has no discriminatory role in paraproteinaemia nor a prognostic role in multiple myeloma

10 November 2019

cites work

1 reference

12 December 2020

Th1 and Th2 in human diseases

1 reference

12 December 2020

Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients

1 reference

12 December 2020

Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma.

1 reference

12 December 2020

Functional diversity of helper T lymphocytes

1 reference

12 December 2020

Regulation of T cell-dependent and -independent IL-12 production by the three Th2-type cytokines IL-10, IL-6, and IL-4

1 reference

12 December 2020

Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells

1 reference

12 December 2020

Function and clinical use of interleukin-12.

1 reference

12 December 2020

IL-12 induces T helper 1-directed antitumor response

1 reference

12 December 2020

Serum interleukin-10 in plasma-cell dyscrasias

1 reference

12 December 2020

Type 1 versus type 2 cytokine release by Vbeta T cell subpopulations determines in vivo antitumor reactivity: IL-10 mediates a suppressive role

1 reference

12 December 2020

Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors

1 reference

12 December 2020

Generation of virtually pure and potentially proliferating dendritic cells from non-CD34 apheresis cells from patients with multiple myeloma

1 reference

12 December 2020

Multiple myeloma: increasing evidence for a multistep transformation process

1 reference

12 December 2020

Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF

1 reference

12 December 2020

CD8+/CD57+cells and apoptosis suppress T-cell functions in multiple myeloma

1 reference

12 December 2020

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

1 reference

12 December 2020

Anti-idiotypic T-cell activation in multiple myeloma induced by M-component fragments presented by dendritic cells

1 reference

12 December 2020

Fas/Fas ligand (FasL)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells

1 reference

12 December 2020

High frequency of specific CD8+ T cells in the tumor and blood is associated with efficient local IL-12 gene therapy of cancer

1 reference

12 December 2020

T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma

1 reference

12 December 2020

Isolation of human lymphocyte antigens class I-restricted cytotoxic T lymphocytes against autologous myeloma cells.

1 reference

12 December 2020

Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12

1 reference

12 December 2020

Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12

1 reference

12 December 2020

Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients.

1 reference

12 December 2020

Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis

1 reference

12 December 2020

Inhibition of Th1 Differentiation by IL-6 Is Mediated by SOCS1

1 reference

12 December 2020

Myeloma proteins as tumor-specific transplantation antigens

1 reference

12 December 2020

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

12 December 2020

Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status

1 reference

12 December 2020

Anti-idiotypic antibodies in patients with monoclonal gammopathies: relation to the tumour load

1 reference

12 December 2020

A disturbance of the IL-2/IL-2 receptor system parallels the activity of multiple myeloma

1 reference

12 December 2020

Identifying strategies for immune intervention

1 reference

12 December 2020

Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells

1 reference

12 December 2020

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

12 December 2020

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production

1 reference

12 December 2020

Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.

1 reference

12 December 2020

Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group

1 reference

12 December 2020

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

1 reference

12 December 2020

Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients

1 reference

12 December 2020

Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies

1 reference

12 December 2020

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

12 December 2020

Human tumor antigens for cancer vaccine development

1 reference

12 December 2020

10.1046/J.1365-2249.2001.01582.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11529908%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference